catechin has been researched along with Cerebral Arteriosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraghis, E; Bélanger, É; Bolduc, V; Drouin, A; Ferland, G; Fernandes, P; Gillis, MA; Hamel, E; Lesage, F; Thorin, E; Thorin-Trescases, N; Villeneuve, L | 1 |
| Baraghis, E; Bolduc, V; Duquette, N; Lambert, J; Lesage, F; Thorin, E; Thorin-Trescases, N | 1 |
2 other study(ies) available for catechin and Cerebral Arteriosclerosis
| Article | Year |
|---|---|
Catechin treatment improves cerebrovascular flow-mediated dilation and learning abilities in atherosclerotic mice.
Topics: Animals; Apolipoprotein B-100; Blood Pressure; Brain; Catechin; Cerebral Arteries; Cerebrovascular Circulation; Cholesterol; Heart Rate; Intracranial Arteriosclerosis; Learning; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Triglycerides; Vasodilation; Vasodilator Agents | 2011 |
Catechin prevents severe dyslipidemia-associated changes in wall biomechanics of cerebral arteries in LDLr-/-:hApoB+/+ mice and improves cerebral blood flow.
Topics: Animals; Antioxidants; Apolipoproteins B; Biomechanical Phenomena; Catechin; Cerebral Arteries; Cerebrovascular Circulation; Compliance; Disease Models, Animal; Dyslipidemias; Endothelium, Vascular; Enzyme Precursors; Genotype; Humans; Intracranial Arteriosclerosis; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Phenotype; Receptors, LDL; Severity of Illness Index; Stress, Mechanical; Tomography, Optical Coherence; Vasodilation | 2012 |